RxDoctor Payments Data

Amy McMichael, MD

Dermatology · Winston Salem, NCNPI 1134104177

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Pfizer at 45.2% of the total. Among dermatology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$309,141in general payments, 2019–2025

Across 230 payments — averaging $1344.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$140K
  • UCB, Inc.$47K
  • Eli Lilly$23K
  • Sun Pharmaceutical Industries Inc.$19K
  • Lilly USA, LLC$17K
  • Aclaris Therapeutics, Inc.$10K
  • plus $55K from 15 others
$467,063in research payments, 2019–2025

Across 124 payments — averaging $3766.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Incyte Corporation$241K
  • Sun Pharmaceutical Industries Inc.$205K
  • Pfizer$14K
  • Aclaris Therapeutics, Inc.$6K
  • AbbVie$1K

What the payments were for

  • Consulting fees$159,05251%
  • Speaking & faculty fees$131,58243%
  • Grants$1,2050%
  • Travel & lodging$12,5194%
  • Food & beverage$4,5411%
  • Education$2420%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$309,141 in reported general payments places this provider in the 95th percentile of 475 dermatology providers in North Carolina.

See all dermatology providers in North Carolina

Medicare billing

Part B allowed, 2024
$38,702
Medicare patients
341
Services billed
840

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab12$89,361
Dupixent PenDupilumab17$61,315
Clobetasol Propionate162$7,521
Ketoconazole166$3,661
Hydroxychloroquine Sulfate84$3,343
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc42$2,462
Finasteride250$2,328
Tretinoin26$2,275
Fluocinonide43$2,185
Minoxidil218$2,074
Fluocinolone AcetonideFluocinolone/Shower Cap38$1,955
Tacrolimus25$1,718
Betamethasone Dipropionate33$1,448
Triamcinolone Acetonide90$1,238
Metronidazole16$1,237

Paid to pharmacies, not to this prescriber.

Other dermatology in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →